Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Can we consider discontinuing primary prophylaxis in adults with severe haemophilia?

Haemophilia : the official journal of the World Federation of Hemophilia - 1 Jul 2008

Fischer K

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Coagulation Factors
Share to Hemophilia A
Share to Hemorrhage
Share to Phenotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 18494687
DOI: 10.1111/j.1365-2516.2008.01733.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Can we consider discontinuing primary prophylaxis in adults with severe haemophilia?PMID 18494687Read ↗

Key issues in inhibitor management in patients with haemophilia.Semantic proximity Read ↗

Why do inhibitors arise in patients with haemophilia A?Semantic proximity Read ↗

Prophylaxis for severe hemophilia: experience from Europe and the United States.Semantic proximity Read ↗

Individualizing primary prophylaxis in patients with hemophilia A and B, adherence and new products.Semantic proximity Read ↗

Assessing risk factors: prevention of inhibitors in haemophilia.Semantic proximity Read ↗

Impact of timing of prophylaxis commencement, F8 genotype and age on factor consumption and health-related quality of life in patients with severe haemophilia A.Semantic proximity Read ↗

Factor VIII/factor IX prophylaxis for severe hemophilia.Semantic proximity Read ↗

Delphi Consensus Recommendations for the Definition of a Severe Bleeding Phenotype and Initiation of Prophylaxis in Patients With Non-Severe Haemophilia.Semantic proximity Read ↗

Hemophilia: treatment options in the twenty-first centurySemantic proximity Read ↗

On‐demand treatment of bleeds in haemophilia patients with inhibitors: strategies for securing and maintaining predictable efficacy with recombinant activated factor VIISemantic proximity Read ↗

Clinical phenotype of severe and moderate haemophilia: Who should receive prophylaxis and what is the target trough level?Semantic proximity Read ↗

Making anticoagulation safer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.